The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells

Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166985. doi: 10.1016/j.bbadis.2023.166985. Epub 2023 Dec 6.

Abstract

Background and aims: Triple Negative Breast Cancer (TNBC) is associated with increased angiogenesis, which is known to aid tumour growth and metastasis. Anti-angiogenic therapies that have been developed to target this feature have mostly generated disappointing clinical results. Further research into targeted approaches is limited by a lack of understanding of the in situ molecular profile of tumour-associated vasculature. In this study, we aimed to understand the differences in the molecular profiles of tumour endothelial cells vs normal-adjacent endothelial cells in TNBC tissues.

Method: We have applied unbiased whole transcriptome spatial profiling of in situ gene expressions of endothelial cells localized in full-face patient TNBC tissues (n = 4) and normal-adjacent regions of the same patient breast tissues.

Results: Our comparative analysis revealed that 2412 genes were differentially expressed (padj < 0.05) between the tumour endothelial cells and normal-adjacent endothelial cells. Pathway enrichment showed the enrichment of gene sets related to cell-cell, cell-ECM adhesion, chromatin organization and remodeling, and protein-DNA complex subunit organization.

Conclusion: Overall, the results revealed unique molecular profiles and signalling pathways of tumour-associated vasculature, which is a critical step towards larger cohort studies investigating potential targets for TNBC prognosis and anti-angiogenic treatments.

Keywords: Abnormal vasculature; Spatial profiling; Triple Negative Breast Cancer; Tumour endothelial cells; Whole transcriptome analyses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endothelial Cells / metabolism
  • Gene Expression Profiling
  • Humans
  • Signal Transduction / genetics
  • Transcriptome*
  • Triple Negative Breast Neoplasms* / pathology